|
Volumn 33, Issue 2, 2015, Pages 149-150
|
Illuminating Parkinson's therapy with optogenetics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID;
CLOZAPINE N OXIDE;
DOPAMINE;
DOPAMINE 1 RECEPTOR;
G PROTEIN COUPLED RECEPTOR;
HALORHODOPSIN;
OXIDOPAMINE;
RHODOPSIN;
BRAIN CORTEX;
BRAIN ELECTROPHYSIOLOGY;
CELL MEMBRANE DEPOLARIZATION;
CORPUS STRIATUM;
DOPAMINE RELEASE;
DOPAMINERGIC NERVE CELL;
EMBRYONIC STEM CELL;
EXCITATORY POSTSYNAPTIC POTENTIAL;
HUMAN;
IMMUNOMODULATION;
MESENCEPHALON;
MOTOR PERFORMANCE;
NEURAL STEM CELL TRANSPLANTATION;
NONHUMAN;
OPTOGENETICS;
PARACRINE SIGNALING;
PARKINSON DISEASE;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
SHORT SURVEY;
SYNAPTIC TRANSMISSION;
THALAMUS;
CELL DIFFERENTIATION;
GENETICS;
METABOLISM;
PROCEDURES;
TRANSPLANTATION;
CELL DIFFERENTIATION;
DOPAMINERGIC NEURONS;
EMBRYONIC STEM CELLS;
HALORHODOPSINS;
HUMANS;
OPTOGENETICS;
PARKINSON DISEASE;
|
EID: 84923272424
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.3140 Document Type: Short Survey |
Times cited : (29)
|
References (10)
|